Think of our lab as a natural extension of your R&D group. From a short feasibility study to a multi-month impurity isolation programme or fully outsourced chemistry, our chemists deliver regulatory-grade work under signed confidentiality, tracked through weekly milestones and supported by complete spectral packages.
Innovator pharma, generic formulators, biotech start-ups and academic groups all draw on the same offering — bench-level execution, analytical depth and the regulatory paperwork that every serious R&D engagement requires.
Start a CRO ProjectLiterature review, retrosynthetic analysis and feasibility-scale benchwork to de-risk a target molecule before committing to a defined route.
Yield enhancement, solvent reduction, impurity control and purity tuning — geared for a smooth move to commercial scale.
Isolation, synthesis and ICH-grade characterisation of process, degradation and forced-degradation impurities.
Development and validation of HPLC, GC and LC-MS methods to ICH Q2 expectations, with dossier-ready documentation.
Stress testing under acid, base, oxidative, thermal and photolytic conditions, aligned with ICH Q1A stability principles.
Submission-ready COAs, NMR/Mass/IR spectra and ICH Q3A/Q3B impurity profiles for global regulatory filings.
It is also a project-management challenge, a communication challenge and an audit-trail challenge; we cover all four so your own team can stay focused on the work that only they can do.